CoChat

Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Microglia activation and release of pro‐inflammatory cytokines have been closely linked to glaucoma. However, the mechanisms that initiate these pathways remain unclear. Here, we investigated the role of a pro‐inflammatory cytokine––osteopontin (OPN), in retinal microglia activation process along with the underlying mechanisms in glaucoma. A rat chronic ocular hypertension (COH) model was established presenting an increase in retinal OPN level and activation of microglia. Primary microglia cells were isolated and cultured under a pressure culture system showing heightened expressions of microglia‐derived OPN with changes in inflammatory factors (TNF‐α, IL‐1β, and IL‐6). OPN and OPN neutralizing antibody (Anti‐OPN) interventions were both applied systems for comparison, and cross‐referenced with OPN knockdown in vitro. JAK/STAT, NF‐κB, ERK1/2, and p38 MAPK, recognized as the primary signaling pathways related to microglia activation, were then screened on whether they can facilitate OPN to act on microglia and their impact on specific inhibitors. Thereafter, retrograde labeling of retinal ganglion cells (RGCs) and flash visual evoked potentials (F‐VEP) were used to investigate neuron protection in context of each blockade. Results suggest that OPN is able to enhance the proliferation and activation of retinal microglia in experimental glaucoma which may play a role in the glaucomatous optic neuropathy, and contribute to the eventual RGCs loss and vision function impairment. Such effect may be mediated through the regulation of p38 MAPK signaling pathway.

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.202002218r

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 59 references

Cited by

See all 37

Metadata

Authors
Yu, H., Zhong, H., Li, N., Chen, K., Chen, J., Sun, J., Xu, L., Wang, J., Zhang, M., Liu, X., Deng, L., Huang, P., Huang, S., Shen, X., & Zhong, Y.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
  • Shen, Xi
  • Zhong, Yisheng
Venue
The FASEB Journal
Publisher
Wiley
Published
2021-02-09
Volume
35
Issue
3
Pages
e21405-e21405
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W3126725218
Cited by
33
References
58
Citations by year
2026: 7 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 5
FWCI
4.25
Type
journal article
Language
en
Open access
closed
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (NO. 81870652, NO. 82070953, NO. 82000885)
  • Health and Family Planning Commission of Sichuan Province (NO. 2020LP034, NO. 2018JP008)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
osteopontin, retinal ganglion cell death, glaucoma, p38 MAPK signaling, chronic ocular hypertension, neuroinflammation, inflammatory cytokines, glaucomatous optic neuropathy, neuroprotection, JAK/STAT signaling, NF-κB, ERK1/2
MeSH terms
Animals, Disease Models, Animal, Evoked Potentials, Visual, Glaucoma, Male, Ocular Hypertension, Retina, Retinal Ganglion Cells, Tumor Necrosis Factor-alpha, Cytokines, Rats, Sprague-Dawley, Microglia, p38 Mitogen-Activated Protein Kinases, Rats, Osteopontin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma. https://app.cochat.ai/papers/10.1096/fj.202002218r
The paper
Yu, H., Zhong, H., Li, N., Chen, K., Chen, J., Sun, J., Xu, L., Wang, J., Zhang, M., Liu, X., Deng, L., Huang, P., Huang, S., Shen, X., & Zhong, Y. (2021). Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma. The FASEB Journal. https://doi.org/10.1096/fj.202002218r

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.